SCHEMBL7049320

SCHEMBL7049320

COC(=O)C(Cc1ccc(Nc2nc3ccccc3n2C)cc1)Nc1c(N2CCCC[C@@H]2C)c(=O)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
OPRM1 P35372 2/20 0.38
OPRK1 P41145 2/20 0.38
OGFRL1 Q5TC84 2/20 0.38
PTGS2 P35354 1/20 0.37
PDE10A Q9Y233 1/20 0.37
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ITGB1 P05556 3/20 0.36
ITGA4 P13612 3/20 0.36
DRD2 P14416 1/20 0.36
TBXA2R P21731 1/20 0.36
ELANE P08246 1/20 0.36
HDAC6 Q9UBN7 4/20 0.35
HDAC3 O15379 3/20 0.35
HDAC1 Q13547 3/20 0.35
HDAC10 Q969S8 3/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049316 1.00 NPC1 (0.39) NPC1RAB9AOPRM1OPRK1OGFRL1
SCHEMBL6888872 0.92 ITGB1 (0.43) OPRM1OPRK1OGFRL1ITGB1ITGA4
SCHEMBL6888873 0.92 ITGB1 (0.43) OPRM1OPRK1OGFRL1ITGB1ITGA4
SCHEMBL6888867 0.90 NPC1 (0.43) NPC1RAB9AOPRM1OPRK1OGFRL1
SCHEMBL6888864 0.90 NPC1 (0.43) NPC1RAB9AOPRM1OPRK1OGFRL1
SCHEMBL6884435 0.77 NPC1 (0.42) NPC1RAB9APDE10AL3MBTL1ITGB1
SCHEMBL7718421 0.73 ITGB1 (0.42) ITGB1ITGA4ALDH1A1HSD17B10
SCHEMBL7718418 0.73 ITGB1 (0.42) ITGB1ITGA4ALDH1A1HSD17B10
SCHEMBL7718426 0.73 ITGB1 (0.42) ITGB1ITGA4ALDH1A1HSD17B10
SCHEMBL6887783 0.73 ELANE (0.42) NPC1RAB9APDE10AL3MBTL1ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6740654-B2 INHIBIT THE BINDING OF INTEGRINS TO THEIR LIGANDS AND ARE OF USE IN THE PROPHYLAXIS AND TREATMENT OF IMMUNE OR INFLAMMATORY DISORDERS, OR DISORDERS INVOLVING THE INAPPROPRIATE GROWTH OR MIGRATION OF CELLS. CELLTECH R & D LIMITED (GB) 2004-05-25 US disclosed
US-20020107263-A1 Squaric acid derivatives CELLTECH R&D, LTD. (GB) 2002-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107263-A1 Squaric acid derivatives SUCNR1, ICAM1, VCAM1 NPC1 1140/4885RAB9A 1901/4885OPRM1 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.